Expression of Survivin, a Novel Inhibitor of Apoptosis, in Superficial Transitional Cell Carcinoma of the Bladder
- 1 February 2004
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 171 (2) , 631-635
- https://doi.org/10.1097/01.ju.0000106082.44786.3b
Abstract
Purpose: We investigated whether the over expression of survivin, a new antiapoptotic protein, might provide prognostic information in patients with superficial bladder cancer.Materials and...Keywords
This publication has 17 references indexed in Scilit:
- THE EFFECT OF ANTISENSE BCL-2 OLIGONUCLEOTIDES ON BCL-2 PROTEIN EXPRESSION AND APOPTOSIS IN HUMAN BLADDER TRANSITIONAL CELL CARCINOMAJournal of Urology, 2001
- Predictive value of topoisomerase IIalpha immunostaining in urothelial bladder carcinomaJournal of Clinical Pathology, 2001
- Prospective Study of Dietary Supplements, Macronutrients, Micronutrients, and Risk of Bladder Cancer in US MenAmerican Journal of Epidemiology, 2000
- Tumor Content of the Antiapoptosis Molecule Survivin and Recurrence of Bladder CancerNew England Journal of Medicine, 1999
- IAP family proteins---suppressors of apoptosisGenes & Development, 1999
- The inhibitors of apoptosis (IAPs) and their emerging role in cancerOncogene, 1998
- A novel anti-apoptosis gene, survivin, expressed in cancer and lymphomaNature Medicine, 1997
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Prevention of Programmed Cell Death of Sympathetic Neurons by the bcl-2 Proto-OncogeneScience, 1992
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958